首页 › 慢性淋巴细胞白血病 › 科罗拉多州 › Denver
Denver CO 慢性淋巴细胞白血病临床试验
9项针对 慢性淋巴细胞白血病的研究正在 Denver及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本（英文）
正在为研究招募参与者？将此页面置顶展示 — $99 / 30天 →
Testing the Addition of Anti-Cancer Drug Sonrotoclax, to the Standard Treatment Zanubrutinib, for Previously Untreated CLL/SLL
招募中3 期
- Kaiser Permanente-Franklin, Denver
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
招募中观察性研究欢迎健康志愿者
- AdventHealth Porter, Denver
A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line (1L) Chronic Lymphocytic Leukemia (CLL)/ Small Lymphocytic Lymphoma (SLL) (MK-1026-011/BELLWAVE-011)
招募中3 期
- Saint Joseph Hospital ( Site 0026), Denver
Single-arm Study of IgPro20 in Adults With Secondary Immune Deficiencies Due to Hematologic Malignancies Treated With B-cell Targeting Chimeric Antigen Receptor T-cell and T-cell Redirecting Therapies
招募中3 期
- CBCI, Colorado Blood Cancer Institute, Denver
A Study of NX-5948 in Adults With CLL/SLL Previously Treated With a Bruton's Tyrosine Kinase Inhibitor and a B-cell Lymphoma-2 Inhibitor (DAYBreak CLL-201)
招募中2 期
- Colorado Blood Institute, Denver
Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)
招募中1/2 期
- Colorado Blood Cancer Institute, Denver
A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies
招募中1 期
- Colorado Blood Cancer Institute, Denver
A Study of NX-2127 in Adults With Relapsed/Refractory B-cell Malignancies
招募中1 期
- Sarah Cannon Research Institute at Colorado Blood Cancer Institute, Denver
A Study of AC676 for the Treatment of Relapsed/Refractory B-Cell Malignancies
招募中1 期
- Colorado Blood Cancer Institute, Denver
其他城市的 慢性淋巴细胞白血病试验
- Boston, MA31 项研究
- Columbus, OH28 项研究
- Durham, NC27 项研究
- Washington, DC22 项研究
- Seattle, WA20 项研究
- Rochester, MN19 项研究
- New York City, NY18 项研究
- Houston, TX17 项研究
- Baldwin Park, CA16 项研究
- Milwaukee, WI15 项研究
- Chicago, IL14 项研究
- Cincinnati, OH14 项研究
Denver的其他研究
- 转移性癌症29 项研究
- 乳腺癌28 项研究
- 多发性骨髓瘤27 项研究
- 非小细胞肺癌27 项研究
- 结直肠癌23 项研究
- 前列腺癌19 项研究
- 黑色素瘤19 项研究
- 癌症（所有类型）18 项研究
- 卵巢癌16 项研究
- 肺癌16 项研究
- 子宫内膜癌15 项研究
- 非霍奇金淋巴瘤14 项研究
数据来自 ClinicalTrials.gov，检索日期：2026年10月5日。每项研究自行设定入选标准，由研究团队决定谁能参与。